Treating pregnant women’s depression with a short course of talk therapy doesn’t just improve their health – it can also shape how their babies’ brains develop before birth . That’s the finding of a new study we co-authored, published in the journal Nature Communications.
The study is part of an ongoing research project that explores how a form of brief interpersonal psychotherapy called MOMCare, which is specially tailored to treating prenatal depression , affects pregnant women with depression and their babies. Mothers joined the research project during the first or second trimester and were randomly assigned to one of two groups. Women in one group received MOMCare. Women in the other group received education about mental health, strategies for managing depression symptoms and referrals to mental health support services, such as therapy, in the community. Both groups continued getting their usual medical care, which could also include referrals to therapy or medication.
MOMCare consists of eight 50-minute sessions focused on building interpersonal skills, reducing conflict and strengthening social support. We enrolled 234 pregnant women who reported having symptoms of depression during their routine prenatal care appointments.
Women who received the MOMCare intervention were also more likely to carry their baby to term , which is linked with shorter hospital stays after birth and improvements in many aspects of child health and development, including better school performance . In the current study, to investigate how this form of talk therapy affects a baby’s developing brain, we measured the volume of different brain areas using an imaging technique called magnetic resonance imaging , or MRI, within a few weeks of birth. In our study, we found that babies with a smaller hippocampal volume at birth tended to respond less negatively than those with larger volume. Even though both MOMCare and the control condition in our study provided more support than pregnant women experiencing symptoms of depression often receive, we still saw a big difference between the groups. This suggests that a targeted intervention, even a noninvasive and relatively low-cost one such as MOMCare, can make a big difference.
In a previous publication, we found that 36% of moms enrolled in our study were diagnosed with depression in pregnancy before getting MOMCare and just 6% after it , showing the intervention was effective. We found that a brain area called the hippocampus , which plays a role in learning, memory and emotional regulation , was 5% smaller by volume in infants whose mothers received MOMCare compared to mothers in the other group.
